FLASH radiotherapy may hold promise as a potential treatment for tough-to-kill tumors

FLASH radiation treatment – which delivers therapeutic doses of radiation in a fraction of a second – may hold promise as a potential treatment for tough-to-kill tumors, a first-in-human study in a small number of people with bone cancer suggests. The technology, previously tested in animals, was shown to be as safe and appeared to be as effective as conventional […]

Continue reading »

Reducing Inflammation May Lower Dementia Risk in RA

The incidence of dementia in patients with rheumatoid arthritis who took either a biologic disease-modifying antirheumatic drug (bDMARD) or targeted synthetic DMARD (tsDMARD) was significantly lower than the rate observed in patients who take only a conventional synthetic DMARD (csDMARD) in a national database study. The work builds on previous research indicating a higher risk of Alzheimer’s disease and related […]

Continue reading »

Study finds lower risk of severe infection and hospitalization with belimumab compared to oral immunosuppressants

New research presented this week at ACR Convergence 2022, the American College of Rheumatology’s annual meeting, found that the biologic B-cell inhibitor belimumab was associated with a lower risk of severe infections and hospitalizations compared to nonbiologic immunosuppressants. Until recently, belimumab was the only FDA-approved biologic for active non-renal systemic lupus erythematosus (SLE or lupus). Although infection is a major […]

Continue reading »

FAQs: Microchipping Your Equine

Microchips have been popular with cats and dogs for decades, but did you know that they are also becoming popular with horses, donkeys and mules as well? In fact, they are even required in some states like Louisiana. Microchipping is an inexpensive and permanent method of identification and can help reunite horses with their owners in case they get lost. […]

Continue reading »

Psilocybin; Climate and Health; and Prostate Cancer Anxiety

Psilocybin Eases Depression A dose of psilocybin with psychotherapy eases symptoms of treatment-resistant depression (TRD) in the short-term, new research shows. Some 29% of patients with TRD who received a single 25-mg dose of synthetic psilocybin experienced a significant reduction in depressive symptoms for at least 3 weeks compared with those in a control group who got 10 mg or 1 mg, […]

Continue reading »

New FDA Approval Expands Use of Cemiplimab in NSCLC

A new approval from the US Food and Drug Administration (FDA) expands the use of the immunotherapy PD-1 inhibitor cemiplimab-rwlc (Libtayo) for patients with non–small cell lung cancer (NSCLC). The new indication is for use of cemiplimab in combination with chemotherapy as a first-line treatment for patients with advanced NSCLC and tumors without mutations (no EGFR, ALK, or ROS1 aberrations) […]

Continue reading »
1 292 293 294 295 296 1,322